Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 2,500 shares at $321.94 ($810K) on 2021-03-29, disclosed to the SEC on 2021-03-31.
Open-market sale of $810k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $321.94 | 300 | $97K | 11.9% |
| 2 | $323.31 | 395 | $128K | 15.8% |
| 3 | $323.31 | 395 | $128K | 15.8% |
| 4 | $324.14 | 378 | $123K | 15.1% |
| 5 | $324.14 | 378 | $123K | 15.1% |
| 6 | $325.56 | 200 |
| $65K |
| 8.0% |
| 7 | $326.29 | 227 | $74K | 9.1% |
| 8 | $326.29 | 227 | $74K | 9.1% |
| Total | $324.12 avg | 2,500 | $810K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |